| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/17/2023 | 459.63% | HC Wainwright & Co. | → $5.5 | Initiates Coverage On | → Buy |
| 11/22/2022 | 205.25% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
| 01/20/2022 | 764.88% | Laidlaw & Co. | → $8.5 | Initiates Coverage On | → Buy |
| 01/11/2022 | 815.75% | Aegis Capital | → $9 | Initiates Coverage On | → Buy |
What is the target price for Cingulate (CING)?
The latest price target for Cingulate (NASDAQ: CING) was reported by HC Wainwright & Co. on January 17, 2023. The analyst firm set a price target for $5.50 expecting CING to rise to within 12 months (a possible 459.63% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cingulate (CING)?
The latest analyst rating for Cingulate (NASDAQ: CING) was provided by HC Wainwright & Co., and Cingulate initiated their buy rating.
When is the next analyst rating going to be posted or updated for Cingulate (CING)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cingulate, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cingulate was filed on January 17, 2023 so you should expect the next rating to be made available sometime around January 17, 2024.
Is the Analyst Rating Cingulate (CING) correct?
While ratings are subjective and will change, the latest Cingulate (CING) rating was a initiated with a price target of $0.00 to $5.50. The current price Cingulate (CING) is trading at is $0.98, which is within the analyst's predicted range.